302912-21-6 Usage
Uses
Used in Pharmaceutical Industry:
5-Methoxy-4-methylindole is used as a reactant for the preparation of β-carboline-1-carboxylic acids, which serve as inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MAPK-activated protein kinase 2). This application is significant in the development of treatments for various diseases and conditions involving abnormal cell signaling.
5-Methoxy-4-methylindole is also used as a reactant for the preparation of indolyl and isoquinolinyl anthranilates, which act as PPARδ (peroxisome proliferator-activated receptor delta) partial agonists. These compounds have potential applications in the treatment of metabolic disorders, such as diabetes and obesity, by modulating the activity of PPARδ.
In Chemical Industry:
5-Methoxy-4-methylindole is utilized as a substrate for the synthesis of various indigoid compounds, which are important in the production of dyes and pigments. Its efficacy in this process has been evaluated, making it a valuable component in the chemical industry for the development of new and improved products.
Check Digit Verification of cas no
The CAS Registry Mumber 302912-21-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,2,9,1 and 2 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 302912-21:
(8*3)+(7*0)+(6*2)+(5*9)+(4*1)+(3*2)+(2*2)+(1*1)=96
96 % 10 = 6
So 302912-21-6 is a valid CAS Registry Number.
302912-21-6Relevant articles and documents
Therapeutic diphenyl ether ligands
-
Page/Page column 35, (2010/10/20)
This invention is directed to compounds of formula Ia, Ib or Ic and to pharmaceutical compositions thereof: or a prodrug thereof and a pharmaceutically acceptable carrier, wherein the R groups are defined in the specification; and, in which the dashed line represents an optional double bond. The invention is also directed to methods of treating, diagnosing, and preventing disorders of the central nervous system that are associated with 5HT receptors, including obesity, attention deficit disorder, migraine, depression, epilepsy, anxiety, Alzheimer's disease, withdrawal from drug abuse, pain, schizophrenia, stress-related disorders, panic disorder, sleep disorders, phobias, obsessive compulsive disorder, post-traumatic-stress syndrome, immune system depression, stress-induced gastrointestinal dysfunction, stress-induced cardiovascular dysfunction, and sexual dysfunction.
